SWOG clinical trial number
SWOG-8754

Evaluation of Didemnin B in Disseminated Malignant Melanoma

Closed
Phase
Published
Abbreviated Title
Evaluation of Didemnin B in Disseminated Malignant Melanoma
Activated
01/15/1989
Closed
05/01/1990

Publication Information Expand/Collapse

2008

Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials. [PMID18235113]

EL Korn;PY Liu;SJ Lee;JAW Chapman;D Niedzwiecki;VJ Suman;J Moon;VK Sondak;MB Atkins;EA Eisenhauer;W Parulekar;SN Markovic;S Saxman;JM Kirkwood Journal of Clinical Oncology 26(4):527-534

2001

Gender and other survival predictors in patients with metastatic melanoma on Southwest Oncology Group trials

JM Unger;LE Flaherty;PY Liu;KS Albain;VK Sondak Cancer 91(6):148-1155

1995

Survival and response to treatment in patients (pts) with metastatic melanoma from intraocular primaries (MMIP) on SWOG studies.

K Katato;PY Liu;V Sondak;LE Flaherty ASCO 14:410(#1298)

1994

Didemnin B in metastatic malignant melanoma: a phase II trial of the Southwest Oncology Group

VK Sondak;KJ Kopecky;PY Liu;WS Fletcher;WH Harvey;LR Laufman Anti-Cancer Drugs 5:147-150